Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery

Saudi Journal of Anaesthesia

Volumn 7, Issue 3, 2013, Pages 301-304

  Abdel Meguid, M E ^a   Essam, M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

CABG; coronary revascularization; recombinant activated factor VII

Indexed keywords

HEPARIN; PHENYLEPHRINE; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHEST TUBE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTIVE SURGERY; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 84882285843     PISSN: 1658354X     EISSN: 09753125     Source Type: Journal    
DOI: 10.4103/1658-354X.115364     Document Type: Article

References (10)

1. Steiner ME, Key NS, Levy JH. Activated recombinant factor VII in cardiac surgery. Curr Opin Anaesthesiol 2005;18:89-92.
2. Gill R, Herbertson M, Diprose P. New alternatives for control of severe cardiac surgical bleeding. Semin Hematol 2004;41:174.
3. Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, et al. Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis. Transfusion 2005;45:26-34.
4. Vanek T, Straka Z, Hrabak J, Jares M, Brucek PJ, Votava J. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding. Jpn Heart J 2004;45:855-60.
5. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996;111:1037-46.
6. Hedner U, Ingerslev J. Clinical use of recombinant FVIIa (rFVIIa). Transfus Sci 1998;19:163-76.
7. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002;53:313-25.
8. Hall TS, Sines JC, Spotnitz AJ. Hemorrhage related reexploration following open heart surgery: The impact of pre-operative and post-operative coagulation testing. Cardiovasc Surg 2002;10:146-53.
9. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005;95:596-602.
10. Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, et al. Recombinant activated factor VII in cardiac surgery: A systematic review. Ann Thorac Surg 2007;83:707-14.